Ranbaxy to provide AIDS drugs to 10 lakh patients
By New Delhi: | 29 Nov 2002
Commenting today on the forthcoming occasion of `Worlds AIDS Day' on December 1, Dr Brian W Tempest, president, pharmaceuticals, Ranbaxy Laboratories said: "Ranbaxy has always been at the forefront in addressing the healthcare needs by providing cost-effective and quality medicines. To address the growing menace of HIV around the world, Ranbaxy will pledge to serve a large part of the global demand of anti-retrovirals (ARVs)".
Ranbaxy's commitment to this segment is evident from the fact that it has filed 300 registrations in 54 countries during the last 18 months.
During
the past one year alone, Ranbaxy has made around 100 registrations/marketing
authorisations with products available in almost 20 countries.
Six anti-AIDS products have also been pre-qualified by
WHO of which four are ARVs, more than offered by any other
generic company.
.webp)
.webp)
.webp)
